Celldex Therapeutics Inc (NAS:CLDX)
$ 35.23 +1.17 (+3.43%) Market Cap: 2.77 Bil Enterprise Value: 2.32 Bil PE Ratio: 0 PB Ratio: 5.14 GF Score: 57/100

Celldex Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 25, 2026 / 01:00PM GMT
Release Date Price: $34.09 (+0.92%)
Operator

Good morning. Sarah Cavanaugh from Celldex will open the meeting. Sarah.

Sarah Cavanaugh
Celldex Therapeutics Inc - Senior Vice President - Corporate Affairs and Administration

Thank you. Welcome to the Annual Meeting of Stockholders of Celldex Therapeutics being held this year by remote communication. Please note that any non-historical statements the company will make today will constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from these statements as a result of a number of risks and uncertainties, including the risk that Celldex has cited in its most recent 10-K and 10-Q filings with the Securities and Exchange Commission and that Celldex typically cites in its press releases.

Also, I would like to remind everyone that this meeting is not a public forum for the purposes of the SEC's Regulation FD. As a result, while we will provide you with general background information about Celldex, we will not be providing any material non-public information at this meeting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot